What is REZVOGLAR? REZVOGLAR is man-made insulin used to control high blood sugar in adults with diabetes mellitus. REZVOGLAR should not be used to treat diabetic ketoacidosis. It is not known if REZVOGLAR is safe to use in children less than 6 years of age with type 1 diabetes. It is not known if REZVOGLAR is safe to use in children with type 2 diabetes. Who should not use REZVOGLAR? Do not use REZVOGLAR if you: are having an episode of low blood sugar (hypoglycemia). have an allergy to insulin glargine products or any of the ingredients in REZVOGLAR. What should I tell my doctor before using REZVOGLAR? Before using…

What is FYLNETRA and what is it used for? FYLNETRA is a prescription medicine used to prevent Chemotherapy-induced Neutropenia and treat the symptoms of Hematopoietic Subsyndrome of Acute Radiation Syndrome. FYLNETRA may be used alone or with other medications. FYLNETRA is a man-made form of G-CSF or granulocyte colony-stimulating factor. G-CSF stimulates the growth of neutrophils, a type of white blood cell that is important in the body’s fight against infection. INDICATIONS FYLNETRA is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia. Who should not take FYLNETRA? FYLNETRA is contraindicated in patients who…

What is Alymsys and what is it used for? Alymsys is a vascular endothelial growth factor inhibitor indicated for the treatment of: Metastatic colorectal cancer, in combination with intravenous (into the veins) fluorouracil-based chemotherapy for first- or second-line treatment. Metastatic colorectal cancer, in combination with fluoropyrimidine-oxaliplatin or fluoropyrimidine-irinotecan-based chemotherapy for second-line treatment in patients who have progressed on a first-line bevacizumab product-containing regimen. Locally advanced, unresectable, recurrent, or metastatic non-squamous non-small cell lung cancer, in combination with paclitaxel and carboplatin for first-line treatment. Recurrent glioblastoma in adults. Metastatic renal cell carcinoma in combination with interferon alfa. Recurrent, persistent, or metastatic cervical cancer, in combination with cisplatin and paclitaxel, or topotecan…

What is BLENREP? BLENREP is an injection available as a prescription used to treat adults with multiple myeloma who: have received at least 4 prior medicines to treat multiple myeloma, and their cancer did not respond to prior treatment or has come back. It is not known if BLENREP is safe to use in children. Contraindications: None. What should I tell my doctor before receiving BLENREP? Before receiving BLENREP, tell your healthcare provider about all of your medical conditions, including if you: have a history of vision or eye problems. have bleeding problems or a history of bleeding problems. are pregnant or planning to become pregnant. BLENREP can harm your…

What is ADAKVEO? ADAKVEO is an injection available as a prescription used to treat sickle cell disease in people 16 years of age and older to help reduce how often painful crises happen. It is not known if ADAKVEO is safe to use in children under 16 years of age. Contraindications None. What should I tell my doctor before using ADAKVEO? Before receiving ADAKVEO, tell your doctor about all of your medical conditions, including if you: are pregnant or planning to become pregnant. ADAKVEO may harm your unborn baby. are breastfeeding or planning to breastfeed. It is not known if ADAKVEO can pass into your breast milk. Tell your doctor…

What is ADBRY? ADBRY is an injection available as a prescription used to treat adults with moderate-to-severe eczema that is not well controlled with prescription therapies used on the skin, or who cannot use topical therapies. It can be used with or without topical corticosteroids. It is not known if ADBRY is safe to use in children. Contraindications:  ADBRY shouldn’t be used in patients who have known hypersensitivity to tralokinumab-ldrm or any excipients in ADBRY. How effective is ADBRY? The effectiveness of ADBRY was studied in 3 separate clinical trials of almost 2,000 adults. In all 3 clinical trials where adults used Adbry every other week, more patients experienced relief at 4 months,…

What is SAPHNELO? SAPHNELO is an injection available as a prescription used to treat adults with moderate to severe systemic lupus erythematosus (SLE or lupus) who are receiving other lupus medicines. SAPHNELO is given together with other medicines for lupus and may help to reduce your lupus disease activity more than other lupus medicines alone. It is not known if SAPHNELO is safe to use in people with severe active lupus nephritis or central nervous system lupus. It is not known if SAPHNELO is safe to use in children under 18 years of age. Limitations of Use: SAPHNELO shouldn’t be used in patients with severe active lupus nephritis or severe…

What is RYBREVANT? RYBREVANT is an injection available as a prescription used to treat adults with non-small cell lung cancer (NSCLC) that: is metastatic (has spread to other parts of the body) or cannot be removed by surgery, and has an abnormal epidermal growth factor receptor “EGFR” gene(s) and whose disease has worsened while on chemotherapy or after chemotherapy that contains platinum. Your doctor will do a test to make sure that RYBREVANT is right for you. It is not known if RYBREVANT is safe to use in children. How effective is RYBREVANT? 40% of the people who were treated with RYBREVANT after chemotherapy that contains platinum saw their tumors disappear (3.7%)…